
      


 
 
|
 |
 |
 |
 |
 |
  
    
 |
 |
 |
 |
Dr. Ellen Scherl is an Assistant Professor of Medicine and an Assistant Attending Physician at the New York Presbyterian Hospital-Weill Medical College of Cornell University, specializing in the medical treatment of ulcerative colitis and Crohn's disease. In her role as Director of the Inflammatory Bowel Disease Center, she helped establish a tissue bank for IBD at Cornell. The IBD Center is committed to clinical practice and research as well as the pathobiology of inflammatory bowel disease.
Dr. Scherl graduated from Barnard College, Columbia University. She completed her internship and residency training at Beth Israel Medical Center and her fellowship in gastroenterology at Mt. Sinai Medical Center, where she remained as a member of the full-time faculty. She is board certified in internal medicine and gastroenterology. Dr. Scherl has contributed numerous articles, reviews, commentaries, and book reviews on inflammatory bowel disease. She is the principal investigator and participates in numerous clinical trials involving the treatment of inflammatory bowel disease. On the NYSGE faculty since 1986, she has been both president and director of their Annual Course. Through her affiliation with the New York branch of the Crohn's and Colitis Foundation beginning 1983, she has helped to develop such curricula as the CCFA Annual IBD Education Day, IBD Coping Seminar Series, Intracity Rounds for GI Fellows, and the first Intracity Symposium on the Doctor-Patient Relationship. Dr. Scherl was the recipient of the Crohn's and Colitis Foundation's Woman of Distinction Award in 1996. She is past president and council member of the New York Society for Gastrointestinal Endoscopy (NYSGE), chair of the Board of Trustees for the Crohn's and Colitis Foundation of America in NYC, also serving on the executive committee, and vice president of the Medical Advisory Committee. She is also a fellow of the American College of Physicians and a member of the American College of Gastroenterology, The New York Academy of Sciences, the American Association for the Advancement of Science, and on the executive committee of the Scleroderma Federation Medical and Scientific Advisory Board.
|
|
     |
|
 |
|